FILE PHOTO: The Johnson & Johnson logo is displayed on a screen on the floor of the New York Stock Exchange. REUTERS/Brendan McDermid
January 14, 2022
(Reuters) – Johnson & Johnson on Friday said it had agreed to pay $44 million to resolve claims that it fueled the opioid epidemic in New Mexico, a state which originally opted against participating in a nationwide settlement resolving thousands of similar cases.
The drugmaker said the $44 million was consistent with the terms of a proposal for J&J and drug distributors McKesson Corp, AmerisourceBergen Corp and Cardinal Health Inc to pay up to $26 billion to resolve the cases nationally.
(Reporting by Nate Raymond in Boston; Editing by Leslie Adler)